Literature DB >> 20060787

Excitatory responses of cardiovascular activities to urocortin3 administration into the PVN of the rat.

Xia Li1, MingXin Fan, Linlin Shen, YinXiang Cao, DaNian Zhu, Zhen Hong.   

Abstract

Urocortin3 (Ucn3) is an endogenous ligand for corticotropin-releasing factor receptor subtype 2 (CRF2R). In this study, we examined its potential cardiovascular effects by microinjection of Ucn3 and anti-sauvagine 30 (ASV30), a selective antagonist of CRF2R, into the paraventricular nucleus (PVN) of the hypothalamus. After Ucn3 (10 pmol/100 nl) was microinjected into the PVN of anesthetized rats, significant increases of systolic blood pressure, heart rate and renal sympathetic nerve activity were observed. Furthermore, all these cardiovascular and autonomic effects induced by Ucn3 could be blocked totally by administration of ASV30 into the PVN. These results are consistent with the idea that Ucn3 might be involved in the central nervous control of cardiovascular function by acting centrally to increase sympathetic outflow via the activation of CRF2R within the PVN. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060787     DOI: 10.1016/j.autneu.2009.12.004

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  9 in total

1.  Urocortin 3 elevates cytosolic calcium in nucleus ambiguus neurons.

Authors:  G Cristina Brailoiu; Elena Deliu; Andrei A Tica; Vineet C Chitravanshi; Eugen Brailoiu
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

2.  Bradycardic effects of microinjections of urocortin 3 into the nucleus ambiguus of the rat.

Authors:  Vineet C Chitravanshi; Kazumi Kawabe; Hreday N Sapru
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-09-26       Impact factor: 3.619

3.  Microinjections of urocortin1 into the nucleus ambiguus of the rat elicit bradycardia.

Authors:  Vineet C Chitravanshi; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-15       Impact factor: 4.733

4.  Mechanisms of cardiovascular actions of urocortins in the hypothalamic arcuate nucleus of the rat.

Authors:  Vineet C Chitravanshi; Kazumi Kawabe; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-17       Impact factor: 4.733

Review 5.  G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei--serpentine gateways to neuroendocrine homeostasis.

Authors:  Georgina G J Hazell; Charles C Hindmarch; George R Pope; James A Roper; Stafford L Lightman; David Murphy; Anne-Marie O'Carroll; Stephen J Lolait
Journal:  Front Neuroendocrinol       Date:  2011-07-23       Impact factor: 8.606

6.  Anatomical Organization of Urocortin 3-Synthesizing Neurons and Immunoreactive Terminals in the Central Nervous System of Non-Human Primates [Sapajus spp.].

Authors:  Daniella S Battagello; Giovanne B Diniz; Paulo L Candido; Joelcimar M da Silva; Amanda R de Oliveira; Kelly R Torres da Silva; Claudimara F P Lotfi; José A de Oliveira; Luciane V Sita; Cláudio A Casatti; David A Lovejoy; Jackson C Bittencourt
Journal:  Front Neuroanat       Date:  2017-07-24       Impact factor: 3.856

7.  Peripheral α2-β1 adrenergic interactions mediate the ghrelin response to brain urocortin 1 in rats.

Authors:  Koji Yakabi; Yumi Harada; Kiyoshige Takayama; Shoki Ro; Mitsuko Ochiai; Seiichi Iizuka; Tomohisa Hattori; Lixin Wang; Yvette Taché
Journal:  Psychoneuroendocrinology       Date:  2014-09-16       Impact factor: 4.905

8.  Effects of stresscopin on rat hypothalamic paraventricular nucleus neurons in vitro.

Authors:  Chun-Ping Chu; Wen-Zhe Jin; Yan-Hua Bing; Qing-Hua Jin; Hiroshi Kannan; De-Lai Qiu
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

9.  Corticotropin releasing factor excites neurons of posterior hypothalamic nucleus to produce tachycardia in rats.

Authors:  He-Ren Gao; Qian-Xing Zhuang; Bin Li; Hong-Zhao Li; Zhang-Peng Chen; Jian-Jun Wang; Jing-Ning Zhu
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.